Wave Life Sciences Ltd. (WVE) › Operating IncomeWave Life Sciences Ltd. (WVE) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2013: -$3.57M2014: -$5.39M2015: -$19.30M2016: -$55.72M2017: -$102.39M2018: -$159.52M2019: -$208.32M2020: -$153.38M2021: -$127.02M2022: -$162.72M2023: -$68.00M2024: -$110.40M2025: -$215.38M-$215.38M2013Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$215.38M-95.1%2024-$110.40M-62.4%2023-$68.00M+58.2%2022-$162.72M-28.1%2021-$127.02M+17.2%2020-$153.38M+26.4%2019-$208.32M-30.6%2018-$159.52M-55.8%2017-$102.39M-83.8%2016-$55.72M-188.7%2015-$19.30M-257.8%2014-$5.39M-50.9%2013-$3.57M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share